TMCnet News
Mersana Therapeutics to Present at the Jefferies 2019 Global Healthcare ConferenceCAMBRIDGE, Mass., May 30, 2019 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that Anna Protopapas, President and Chief Executive Officer, will present a company overview at the Jefferies 2019 Global Healthcare Conference in New York City, NY on Thursday, June 6, 2019 at 8:30 a.m. ET. A live webcast of the presentation will be available on the Investors & Media section of Mersana’s website at www.mersana.com. Archived replays will be available for approximately 90 days following the presentation. About Mersana Therapeutics Contact: Investor & Media Contact |